{"id":"W4295837070","doi":"10.1016/j.annonc.2022.07.1826","title":"1748P 4-factor model to predict response and survival benefit with durvalumab (D) in previously treated metastatic urinary tract carcinoma (mUTC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Durvalumab; Oncology; Internal medicine; Urinary system; Carcinoma; Urology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009545492,0.0005675042,0.000697435,0.000630075,0.0001715033,0.0006475421,0.0004565326,0.0004714221,0.003317961],"category_scores_gemma":[0.00240564,0.0001264238,0.001025177,0.0002844661,0.0001363023,0.0002700092,0.0003526109,0.0007028945,0.0005280255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006493261,"about_ca_system_score_gemma":0.0007233577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004604866,"about_ca_topic_score_gemma":0.003160311,"domain_scores_codex":[0.9997926,0.00008297895,0.00001143197,0.00003878549,0.00003102631,0.00004314085],"domain_scores_gemma":[0.9993526,0.0004135288,0.00007622971,0.00002256596,0.00006180822,0.00007321054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.02462075,0.001137901,0.5677915,0.0002480091,0.002831004,0.0008582895,0.00005484748,0.1966388,0.005969808,0.001234401,0.01213464,0.1864802],"study_design_scores_gemma":[0.0006883822,0.001914326,0.09048513,0.00006414411,0.001341113,0.0004234943,0.00006983266,0.8970097,0.001732326,0.002223006,0.004007436,0.0000410442],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859802,0.001704307,0.006575304,0.001175874,0.000153708,0.00005377598,0.002083739,0.0001816824,0.002091381],"genre_scores_gemma":[0.9956564,0.0001563217,0.001486212,0.0001032796,0.00003584499,0.00002977512,0.001428683,0.00001527622,0.00108814],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004604866,"threshold_uncertainty_score":0.01109964,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09783277607515922,"score_gpt":0.3687335523768765,"score_spread":0.2709007763017173,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}